Please assess the completion status of the following clinical trial:

Trial Title: LEGION™ Primary Safety and Efficacy

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria: Subjects must meet all of the inclusion criteria:~* Subject is a candidate for the LEGION™ Primary Knee System according to the instructions for use~* Subject is of legal age and skeletally mature~* Subject is willing to sign and date an ethics-approved consent form and participate in the study~* Subject is willing to be available for ten-year follow-up postoperatively.~Exclusion Criteria: Subjects must not meet any of the exclusion criteria:~* Subject with immunosuppressive disorders~* Subject has grossly insufficient femoral or tibial bone stock~* Subject has an active localized or systemic infection~* Subject is pregnant~* Subject psychological or neurological conditions that would impair the subject's ability or willingness to restrict activities or follow medical advice during the course of this study~* Subject is a prisoner.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- LEGION™ Primary (Type: OTHER): LEGION™ Primary Total Knee Arthroplasty (TKA)

Based on this trial design, predict the completion outcome and termination type (if applicable).